About Nasdepi®

When Every

Minute Matters!

For those facing life-threatening allergic reactions, every moment counts. Meet Nasdepi®, a groundbreaking innovation in anaphylaxis treatment. Living with severe allergies has long meant living with constant worry. Data indicates only 40% of US patients with a prior food allergy diagnosis and a prescription for epinephrine actually carry it with them. We are decades late on a new and better way to treat anaphylaxis that doesn’t require painful, costly intramuscular injections.

The Vision Behind Nasdepi® Works

Simple, Fast, and Effective

Nasdepi® is being developed as a potential solution for managing severe allergic reactions. Its dry-powder formulation aims to provide an alternative to traditional injection methods, delivering epinephrine intranasally via the nasal mucosa. This design seeks to provide a streamlined and efficient way to address the challenges of emergency response for anaphylaxis. With ease of use as a guiding principle, Nasdepi® is intended to offer a user-friendly option that eliminates the need for needle-based delivery systems, making it accessible for use in critical situations.

Nasdepi® vs. Injectable Epinephrine

A Breakthrough in Allergy Care

Challenges with Injectable Epinephrine

Vulnerable to Temperature: Loses efficacy in extreme temperatures.

Needle Phobia: Fear of needles deters quick usage.

Slow Onset Action: Takes ~20-40 minutes to reach full effect.

Prohibitively Expensive to Produce: High costs are passed on to customers, limiting accessibility.

Complex Administration: Injections are difficult to administer without the appropriate training.

Bulky and Inconvenient: Awkward to carry with you.

Short Shelf Life: The patient typically only has 12 months of protection with a liquid product.

Our Dry Powder Epinephrine Solution*: Nasdepi®

Temperature-Stable: 100% reliable in extreme temperatures.

Completely Pain-Free: No needle-injection.

Fast Onset: Reaches full effect faster.

Economically Efficient: More affordable, expanding access.

Effortless and Passive Device: Intuitive device you can administer in seconds, even if the patient is unconscious.

Compact and Lightweight: Half the size of an autoinjector and fits in a pocket.

Extended Shelf Life and Preservative Free: Effective for at least 36 months.

*The features described represent development objectives and are subject to further validation through regulatory review and approval processes.

A New Era in Anaphylaxis Treatment

Nasdepi’s® cutting-edge design is intended to offer a life-saving alternative to ensure patients receive the care they need when every moment counts. Whether at home, work, or on the go, Nasdepi® seeks to provide confidence and peace of mind in treating severe allergic reactions.